Enlivex Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
0.9615
+0.0119 (1.25%)
At close: Apr 10, 2026, 4:00 PM EDT
0.9725
+0.0110 (1.14%)
After-hours: Apr 10, 2026, 7:46 PM EDT
Enlivex Employees
Enlivex had 34 employees as of December 31, 2025. The number of employees decreased by 37 or -52.11% compared to the previous year.
Employees
34
Change
-37
Growth
-52.11%
Revenue / Employee
n/a
Profits / Employee
$36,339,059
Market Cap
228.24M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 34 | -37 | -52.11% |
| Dec 31, 2021 | 71 | 21 | 42.00% |
| Dec 31, 2020 | 50 | 14 | 38.89% |
| Dec 31, 2019 | 36 | 5 | 16.13% |
| Dec 31, 2018 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Codexis | 146 |
| MediWound | 121 |
| Arcturus Therapeutics Holdings | 111 |
| OmniAb | 89 |
| Compugen | 75 |
| Camp4 Therapeutics | 48 |
| ALX Oncology Holdings | 43 |
ENLV News
- 3 days ago - Ondo Global Markets Tokenizes Enlivex's Ordinary Shares - GlobeNewsWire
- 16 days ago - Enlivex Rain Update: Rain Launches an OpenClaw and AI Agent Interface Allowing Anyone To Create A Prediction Market Via A Single Prompt - GlobeNewsWire
- 17 days ago - Enlivex Reports Full-Year 2025 Results: Profit (Net Income) of $1.23 Billion and Diluted Earnings Per Share (EPS) of $25.48 - GlobeNewsWire
- 18 days ago - Enlivex Announces $21 Million Debt Financing, Decentralized Prediction Markets RAIN Token-Related Updates and $20 Million Share Repurchase Program - GlobeNewsWire
- 19 days ago - Quality Longevity Company Enlivex Receives Investigational New Drug (IND) Clearance from the FDA for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis - GlobeNewsWire
- 2 months ago - Enlivex Treasury Portfolio Update: New Listing of the RAIN Token on Kraken, the Second-Largest U.S. Cryptocurrency Exchange - GlobeNewsWire
- 2 months ago - Enlivex Treasury Portfolio Update: Listing of the RAIN Token on WhiteBIT, a Leading Cryptocurrency Exchange - GlobeNewsWire
- 2 months ago - Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq - GlobeNewsWire